WARS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.166400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.706600E-01
Normal-vs-Stage2
6.266800E-01
Normal-vs-Stage3
1.334630E-01
Normal-vs-Stage4
1.089390E-01
Stage1-vs-Stage2
5.124000E-01
Stage1-vs-Stage3
2.437600E-01
Stage1-vs-Stage4
3.390400E-02
Stage2-vs-Stage3
1.622220E-03
Stage2-vs-Stage4
3.829900E-02
Stage3-vs-Stage4
6.316000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.361200E-01
Normal-vs-AfricanAmerican
5.553600E-02
Normal-vs-Asian
4.930000E-01
Caucasian-vs-AfricanAmerican
1.282360E-01
Caucasian-vs-Asian
7.977800E-01
AfricanAmerican-vs-Asian
1.768390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.494800E-01
Normal-vs-Female
6.408000E-01
Male-vs-Female
4.870000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.893600E-01
Normal-vs-Age(41-60Yrs)
3.676400E-01
Normal-vs-Age(61-80Yrs)
6.576400E-01
Normal-vs-Age(81-100Yrs)
5.135800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.176100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.960200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.661200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.057600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.567200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.232400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.675200E-01
Normal-vs-Daily Drinker
7.732400E-01
Normal-vs-Weekly Drinker
2.625000E-01
Normal-vs-Occasional Drinker
4.715600E-01
Normal-vs-Social Drinker
6.582200E-01
Non Drinker-vs-Daily Drinker
8.882200E-01
Non Drinker-vs-Weekly Drinker
2.997400E-01
Non Drinker-vs-Occasional Drinker
2.165600E-01
Non Drinker-vs-Social Drinker
8.311600E-01
Daily Drinker-vs-Weekly Drinker
3.151800E-01
Daily Drinker-vs-Occasional Drinker
2.839600E-01
Daily Drinker-vs-Social Drinker
9.574600E-01
Weekly Drinker-vs-Occasional Drinker
4.792400E-01
Weekly Drinker-vs-Social Drinker
3.187400E-01
Occasional Drinker-vs-Social Drinker
2.939400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.935040E-01
Normal-vs-Grade 2
2.539000E-01
Normal-vs-Grade 3
6.827600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.106980E-01
Grade 1-vs-Grade 3
4.965000E-01
Grade 1-vs-Grade 4
1.935040E-01
Grade 2-vs-Grade 3
2.158000E-01
Grade 2-vs-Grade 4
2.539000E-01
Grade 3-vs-Grade 4
6.827600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.299400E-01
Normal-vs-NonDiabetic
6.588000E-01
Diabetic-vs-NonDiabetic
8.170400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.036400E-01
Normal-vs-NoPancreatitis
6.551400E-01
Pancreatitis-vs-NoPancreatitis
9.534400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.591600E-01
Normal-vs-N1
6.072400E-01
N0-vs-N1
4.756200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.287900E-02
Normal-vs-TP53-NonMutant
3.829200E-01
TP53-Mutant-vs-TP53-NonMutant
5.978800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
